Patent details
EP1429845 Title: TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
Basic Information
- Publication number:
- EP1429845
- PCT Application Number:
- PCT/EP/2002/006278
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027546373
- PCT Publication Number:
- WO/2002/100148
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
- French Title of Invention:
- TRAITEMENT OU PROPHYLAXIE DU REJET DES GREFFES DE CELLULES PRODUISANT DE L'INSULINE
- German Title of Invention:
- BEHANDLUNG UND VORBEUGUNG VON INSULIN-PRODUZIERENDE ZELLTRANSPLANTATABSTOSSUNG
- SPC Number:
Dates
- Filing date:
- 07/06/2002
- Grant date:
- 11/03/2009
- EP Publication Date:
- 11/03/2009
- PCT Publication Date:
- 19/12/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/06/2004
- EP B1 Publication Date:
- 11/03/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/06/2009
- Expiration date:
- 07/06/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/06/2002
- Name:
- NOVARTIS AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- LAKE Philip
- Address:
- United States (US)
2
- Name:
- MULLON Claudy
- Address:
- United States (US)
Priority
- Priority Number:
- 297069 P
- Priority Date:
- 08/06/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61P 37/06;
| Filing date | Document type | Number of pages |
|---|